Accueil • Veille Scientifique • An Iterative Approach Guides Discovery of the FabI Inhibitor Fabimycin, a Late-Stage Antibiotic Candidate with In Vivo Efficacy against Drug-Resistant Gram-Negative Infections
ACS Cent. Sci. • 2022.08.10
Parker E.N., Cain B.C., Hajian B., et al.